Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predictive Value of SFlt-1/PlGF Ratio for the Diagnosis of Cardiovascular Disorders in the Puerperium: Pilot Study
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The goal of this clinical trial is to identify a risk stratification model and its predictive value for cardiovascular/hypertensive disorders in the puerperium (6 weeks postpartum) by making use of a panel of placental biochemical markers (sFlt-1 and PlGF: already used in pregnancy for prediction of preeclampsia), demographic, clinical and laboratory data. The goal is to create a score that allows the clinician to identify those expectant mothers who at discharge are at increased risk of developing cardiovascular/hypertensive disorders.
Key Details
Gender
FEMALE
Age Range
18 Years - 44 Years
Study Type
INTERVENTIONAL
Enrollment
181
Start Date
2022-04-06
Completion Date
2026-12-31
Last Updated
2024-12-09
Healthy Volunteers
Yes
Interventions
Identification of a risk stratification model and its predictive value for cardiovascular disorders in the puerperium
Identification of a risk stratification model for cardiovascular/hypertensive disorders in the puerperium using a panel of placental biochemical markers (sFlt-1 and PlGF: already used in pregnancy for prediction of preeclampsia), demographic, clinical and laboratory data.
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy